Meletios Dimopoulos
www.mendeley.com
0000-0001-8990-3254
National and Kapodistrian University of Athens
82 papers found
Refreshing results…
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth
Missing publications? Search for publications with a matching author name.